perindopril has been researched along with Parkinson Disease, Secondary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, SY; Howells, DW; Jenkins, TA; Mendelsohn, FA; Wong, JY | 1 |
1 other study(ies) available for perindopril and Parkinson Disease, Secondary
Article | Year |
---|---|
Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin-Converting Enzyme Inhibitors; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Parkinson Disease, Secondary; Peptidyl-Dipeptidase A; Perindopril; Receptors, Dopamine D2 | 1999 |